Aeterna Zentaris
is a biopharmaceutical company that develops and commercializes drugs for the treatment of orphan endocrine diseases... Read moreAeterna Zentaris
is a biopharmaceutical company that develops and commercializes drugs for the treatment of orphan endocrine diseases... Read more
News
Aug 09, 2024
MarketScreener
Aeterna Zentaris: Aeterna Zentaris Inc. will Change its Ticker to CSCI from AEZS
Jul 17, 2024
Life Care News
Aeterna Zentaris: Aeterna Zentaris Announces Results of Virtual 2024 Meeting
Jun 13, 2024
GlobeNewswire
Press Release: Aeterna Zentaris : Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Jun 03, 2024
Canadian Manufacturing
Aeterna Zentaris: Aeterna Zentaris and Ceapro announce merger completion
May 16, 2024
MarketScreener
Aeterna Zentaris: Aeterna Zentaris : Condensed Interim Consolidated Financial Statements As of March 31, 2024, and for the three months ended March 31, 2024, and 2023 - Form 6-K
Mar 28, 2024
GlobeNewswire
Aeterna Zentaris: Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Mar 27, 2024
Marketscreener
Aeterna Zentaris: Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb 26, 2024
MarketScreener
Aeterna Zentaris: Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
Feb 23, 2024
MarketScreener
Aeterna Zentaris: Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
Dec 14, 2023
Business Wire
Press Release: Aeterna Zentaris : AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders
Aeterna Zentaris Competitors
1
2
3
4
5
6
7
8
9
10